• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    LAPIX Doses First Patient For Rheumatoid And Psoriatic Arthritis

    GLOBENEWSWIRE

    Lapix Therapeutics Announces Positive Phase 1 Data For LPX-TI641

    GLOBENEWSWIRE

    LAPIX Therapeutics Strengthens Board of Directors

    GLOBENEWSWIRE

    LAPIX Announces First Subjects Dosed in its First-in-Human Study of LPX-TI641

    GLOBENEWSWIRE

    LAPIX Announces FDA Clearance of IND Application for Tim3/4 Agonist LPX-TI641

    GLOBENEWSWIRE

    LAPIX Therapeutics Inc. Announces the Issuance of U.S. Patent for LPX-TI641

    GLOBENEWSWIRE

    LAPIX Announces a Successful Conclusion of its Pre-IND Meeting Request with FDA

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.